(PharmaNewsWire.Com, August 13, 2018 ) Europe Facial Treatment market size was around USD 279.25 million in 2018 It is expected to grow at a CAGR of 7.1% to reach USD 393.5 million by 2023 It captures 30% of the global market.
This market has experienced solid growth in the last decade owing to a number of factors like rising disposable income of urban consumers and the increasing proclivity of consumers to spend growing amounts on cosmetic treatments. Robust economic growth in the emerging economies, resulting in high disposable income levels and lifestyle changes are the primary factors driving market growth. Cosmetically conscious youth and increased aging are the secondary factors driving market growth.In spite of that, inadequately trained professionals and lack of on paper evidence of clinical effectiveness, are the primary restraints of the market.
The market is segmented by product type into laser based devices, IPL devices, RF devices, ultrasound devices, and LED devices. IPL devices are expected to command the market in the forecast period owing to their rising demand in over laser-based devices. This segment is anticipated to be valued at USD 279.25 million in 2018 capturing 29% of the market. Showcasing a robust 6.6% CAGR in the aforementioned forecast period, the IPL devices category is anticipated to rise to USD 393.5 million by the end of 2023
By geography, the market is segmented into UK, Spain, Germany, France, and others. The market is expected a robust growth trajectory in Europe in the forecast period.
Key players in the market include Lutronic Corporation, Cutera Inc., Lynton Lasers Ltd., Sciton Inc., Alma Lasers Ltd., Solta Medical Inc., Lumenis Ltd., Cynosure Inc., Strata Skin Sciences Inc., Syneron Medical Ltd., Venus Concept Canada Corporation, and Fotona d.d.
About MarketDataForecast
Market Data Forecast is a market research firm offering syndicated research, consults and industry newsletters across various domains & verticals. With a well-established in-house team of experts from diverse fields and outsource research network across 100+ countries, we are the sole research providers for the majority of Fortune 500 companies. Along with the standards of reports being on par excellence, our unique services like free customization, analyst support for the period of six months post to the purchase will be the flag bearers and differentiates us from the rest. Our experience and in-depth understanding of various business environments will be a support to you and your organization in making well-informed decisions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
